These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36963168)

  • 1. Prognostic significance of circulating tumor cell measurement in the peripheral blood of patients with nasopharyngeal carcinoma.
    Gao T; Mao J; Huang J; Luo F; Lin L; Lian Y; Bin S; Zhao L; Li S
    Clinics (Sao Paulo); 2023; 78():100179. PubMed ID: 36963168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of circulating tumor cells in predicating the outcomes of patients with colorectal cancer.
    Chen K; Chen Z; Ou M; Wang J; Huang X; Wu Y; Zhong W; Yang J; Huang J; Huang M; Pan D
    Clinics (Sao Paulo); 2022; 77():100070. PubMed ID: 36087570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative Circulating Tumor Cells (CTCs), MCTCs, and CTC-White Blood Cells Detected by a Size-Based Platform Predict Prognosis in Renal Cell Carcinoma.
    Wang Z; Zhang P; Chong Y; Xue Y; Yang X; Li H; Wang L; Zhang Y; Chen Q; Li Z; Xue L; Li H; Chong T
    Dis Markers; 2021; 2021():9956142. PubMed ID: 34733376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Significance of Excision Repair Cross-Complementation Group 1 on Circulating Tumor Cells for Nasopharyngeal Carcinoma.
    Liu T; Li Y; Song J; Li B; Wang R; Huang T; Qin Y
    Cancer Control; 2024; 31():10732748241251562. PubMed ID: 38716503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of COX-2 expression on circulating tumor cells in nasopharyngeal carcinoma: A prospective analysis.
    Li YJ; Luo Y; Xie XQ; Li P; Wang F
    Radiother Oncol; 2018 Nov; 129(2):396-402. PubMed ID: 30082142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of epithelial-mesenchymal transition typing of circulating tumour cells in colorectal cancer.
    Hou J; Guo C; Lyu G
    Colorectal Dis; 2020 May; 22(5):581-587. PubMed ID: 31868956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.
    Guan X; Ma F; Li C; Wu S; Hu S; Huang J; Sun X; Wang J; Luo Y; Cai R; Fan Y; Li Q; Chen S; Zhang P; Li Q; Xu B
    Cancer Commun (Lond); 2019 Jan; 39(1):1. PubMed ID: 30606259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The correlation study between TOP2A gene expression in circulating tumor cells and chemotherapeutic drug resistance of patients with breast cancer.
    Ye JH; Yu J; Huang MY; Mo YM
    Breast Cancer; 2024 May; 31(3):417-425. PubMed ID: 38561479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Tumor Cells and Fibronectin 1 in the Prognosis of Nasopharyngeal Carcinoma.
    Yu Y; Lin ZX; Li HW; Luo HQ; Yang DH; Zhou HC; Jiang DX; Zhan DC; Yang L; Liang XY; Yu ZH; Chen ZH
    Technol Cancer Res Treat; 2020; 19():1533033820909911. PubMed ID: 32281480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of circulating tumor cells in patients with locally advanced head and neck squamous cell carcinoma.
    Liu K; Chen N; Wei J; Ma L; Yang S; Zhang X
    Oncol Rep; 2020 May; 43(5):1525-1535. PubMed ID: 32323844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Significance of Circulating Tumor Cells (CTCs) and Survivin on Predicting Prognosis in Thyroid Cancer Patients.
    Weng X; YangYang ; Cai Y
    Dis Markers; 2022; 2022():5188006. PubMed ID: 35140820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating tumor cells: a valuable indicator for locally advanced nasopharyngeal carcinoma.
    Liu T; Liu J; Wang G; Chen C; He L; Wang R; Ouyang C
    Eur Arch Otorhinolaryngol; 2024 Sep; 281(9):4963-4972. PubMed ID: 38733533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Joint quantitative measurement of hTERT mRNA in both peripheral blood and circulating tumor cells of patients with nasopharyngeal carcinoma and its clinical significance.
    Fu X; Shen C; Wang H; Chen F; Li G; Wen Z
    BMC Cancer; 2017 Jul; 17(1):479. PubMed ID: 28693532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tumor cells with karyotyping as a novel biomarker for diagnosis and treatment of nasopharyngeal carcinoma.
    Zhang J; Shi H; Jiang T; Liu Z; Lin PP; Chen N
    BMC Cancer; 2018 Nov; 18(1):1133. PubMed ID: 30454007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Clinical Values of Circulating Tumor Cells and T Lymphocyte Subsets in Predicting a Prognosis of Lung Cancer.
    Liu X; Yan X; Li J; Mao W; Jiang F
    Clin Lab; 2024 Oct; 70(10):. PubMed ID: 39382904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal circulating tumor cells and Ki67: their mutual correlation and prognostic implications in hepatocellular carcinoma.
    Yang X; Ni H; Lu Z; Zhang J; Zhang Q; Ning S; Qi L; Xiang B
    BMC Cancer; 2023 Jan; 23(1):10. PubMed ID: 36600214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating tumor cells (CTCs) and hTERT gene expression in CTCs for radiotherapy effect with lung cancer.
    Xu Y; Ren X; Jiang T; Lv S; Gao K; Liu Y; Yan Y
    BMC Cancer; 2023 May; 23(1):475. PubMed ID: 37226235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between the cyclooxygenase-2 expression in circulating tumor cells and the clinicopathological features of patients with colorectal cancer.
    Cai J; Huang L; Huang J; Kang L; Lin H; Huang P; Zhu P; Wang J; Dong J; Wang L; Xian CJ
    J Cell Biochem; 2019 Apr; 120(4):4935-4941. PubMed ID: 30260024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers combined with clinicopathological risk has potential to better predict recurrence in stage III breast cancer treated with neoadjuvant chemotherapy: a pilot study.
    Du KY; Wu S; Ma X; Liu Y
    Breast Cancer Res Treat; 2024 Oct; 207(3):517-527. PubMed ID: 38990453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
    Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
    PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.